- Weight-Loss Drugs May Have Surprising Side Effect: Stalling Cancer WSJ
- GLP-1 drugs may reduce the risk of cancer progressing, study suggests NBC News
- GLP-1 drugs may result in better outcomes for cancer patients, study claims The Independent
- ASCO 2026: GLP-1s could reduce the risk of some obesity-related cancers progressing Oncology Central
- Ozempic, Mounjaro Can Reduce Risk Of Cancer Returning In Patients, Finds Study News18